Cargando…

1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018

BACKGROUND: Bordetella pertussis causes a highly contagious, nationally reportable respiratory illness resulting in violent coughing. Pertussis outbreaks continue despite an available vaccine. Appropriate pertussis testing depends on timing from the onset of symptoms. Culture testing within 2 weeks...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirmer, Patricia, Oda, Gina, Lucero-Obusan, Cynthia, Holodniy, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810154/
http://dx.doi.org/10.1093/ofid/ofz360.1504
_version_ 1783462179169632256
author Schirmer, Patricia
Oda, Gina
Lucero-Obusan, Cynthia
Holodniy, Mark
author_facet Schirmer, Patricia
Oda, Gina
Lucero-Obusan, Cynthia
Holodniy, Mark
author_sort Schirmer, Patricia
collection PubMed
description BACKGROUND: Bordetella pertussis causes a highly contagious, nationally reportable respiratory illness resulting in violent coughing. Pertussis outbreaks continue despite an available vaccine. Appropriate pertussis testing depends on timing from the onset of symptoms. Culture testing within 2 weeks from symptom onset is gold standard, while PCR testing is reasonable up to 3–4 weeks and serology testing 2–12 weeks from symptom onset per CDC. We describe pertussis testing in the Department of Veterans Affairs (VA) from 2010–2018. METHODS: VA data sources were queried for all Bordetella pertussis tests (culture, DFA, IgA, IgG, IgM, and PCR) from January 2010 to December 2018. Data were compared across years. A random selection of 10 patient charts with both positive and negative test results for each type of testing were reviewed to determine timing from onset of symptoms to testing. RESULTS: From 2010 to 2018, 37,356 pertussis tests (28,174 unique patients) were performed in VA nationally. Increased testing occurred in 2012 (most recent peak year) and PCR testing increased in 2014 with introduction of multiplex panels. Otherwise testing was stable between years (Figure 1). Positive test results included culture 1/252 (0.4%), DFA 4/204 (2%), IgA 459/1,546 (29.7%), IgM 168/1,189 (14.1%), IgG 1,156/2,291 (50.4%), and PCR 47/31,847 (0.2%) (Figure 2). Total positive tests per year ranged from 161 in 2015 to 313 in 2012. Across the years, IgG was the most common positive test. In 37/60 (62%) charts reviewed, appropriate test was chosen based on duration of symptoms. 9/60 (15%) had no symptom duration documented and 14/60 (23%) did not have appropriate pertussis testing chosen based on symptom duration. DFA testing chart reviews were not included as there is no CDC recommendation for DFA testing in pertussis diagnosis. CONCLUSION: Number of pertussis-positive results remained stable despite increased testing, primarily from multiplex PCR testing. IgG, often a marker of immunity, was the most common test to be positive across the studied timeframe. In a small sampling of patients, about two-thirds received appropriate testing based on symptom duration. With the multitude of pertussis tests ordered, further education of clinicians on appropriate testing based on timing of symptoms is needed. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810154
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68101542019-10-28 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018 Schirmer, Patricia Oda, Gina Lucero-Obusan, Cynthia Holodniy, Mark Open Forum Infect Dis Abstracts BACKGROUND: Bordetella pertussis causes a highly contagious, nationally reportable respiratory illness resulting in violent coughing. Pertussis outbreaks continue despite an available vaccine. Appropriate pertussis testing depends on timing from the onset of symptoms. Culture testing within 2 weeks from symptom onset is gold standard, while PCR testing is reasonable up to 3–4 weeks and serology testing 2–12 weeks from symptom onset per CDC. We describe pertussis testing in the Department of Veterans Affairs (VA) from 2010–2018. METHODS: VA data sources were queried for all Bordetella pertussis tests (culture, DFA, IgA, IgG, IgM, and PCR) from January 2010 to December 2018. Data were compared across years. A random selection of 10 patient charts with both positive and negative test results for each type of testing were reviewed to determine timing from onset of symptoms to testing. RESULTS: From 2010 to 2018, 37,356 pertussis tests (28,174 unique patients) were performed in VA nationally. Increased testing occurred in 2012 (most recent peak year) and PCR testing increased in 2014 with introduction of multiplex panels. Otherwise testing was stable between years (Figure 1). Positive test results included culture 1/252 (0.4%), DFA 4/204 (2%), IgA 459/1,546 (29.7%), IgM 168/1,189 (14.1%), IgG 1,156/2,291 (50.4%), and PCR 47/31,847 (0.2%) (Figure 2). Total positive tests per year ranged from 161 in 2015 to 313 in 2012. Across the years, IgG was the most common positive test. In 37/60 (62%) charts reviewed, appropriate test was chosen based on duration of symptoms. 9/60 (15%) had no symptom duration documented and 14/60 (23%) did not have appropriate pertussis testing chosen based on symptom duration. DFA testing chart reviews were not included as there is no CDC recommendation for DFA testing in pertussis diagnosis. CONCLUSION: Number of pertussis-positive results remained stable despite increased testing, primarily from multiplex PCR testing. IgG, often a marker of immunity, was the most common test to be positive across the studied timeframe. In a small sampling of patients, about two-thirds received appropriate testing based on symptom duration. With the multitude of pertussis tests ordered, further education of clinicians on appropriate testing based on timing of symptoms is needed. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810154/ http://dx.doi.org/10.1093/ofid/ofz360.1504 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Schirmer, Patricia
Oda, Gina
Lucero-Obusan, Cynthia
Holodniy, Mark
1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
title 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
title_full 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
title_fullStr 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
title_full_unstemmed 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
title_short 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
title_sort 1640. pertussis testing in the department of veterans affairs, 2010–2018
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810154/
http://dx.doi.org/10.1093/ofid/ofz360.1504
work_keys_str_mv AT schirmerpatricia 1640pertussistestinginthedepartmentofveteransaffairs20102018
AT odagina 1640pertussistestinginthedepartmentofveteransaffairs20102018
AT luceroobusancynthia 1640pertussistestinginthedepartmentofveteransaffairs20102018
AT holodniymark 1640pertussistestinginthedepartmentofveteransaffairs20102018